Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

Lee AK, Woodward M, Wang D, Ohkuma T, Warren B, Sharrett AR, Williams B, Marre M, Hamet P, Harrap S, McEvoy JW, Chalmers J, Selvin E.

J Clin Endocrinol Metab. 2019 Oct 7. pii: dgz045. doi: 10.1210/clinem/dgz045. [Epub ahead of print]

PMID:
31588504
2.

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.

Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, Hadjadj S, Hamet P, Harrap S, Mancia G, Marre M, Williams B, Chalmers J, Woodward M, Perkovic V; ADVANCE Collaborative Group.

Diabetologia. 2019 Nov;62(11):1988-1997. doi: 10.1007/s00125-019-4948-4. Epub 2019 Jul 13.

3.

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Ohkuma T, Jun M, Chalmers J, Cooper ME, Hamet P, Harrap S, Zoungas S, Perkovic V, Woodward M; ADVANCE Collaborative Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):862-872. doi: 10.2215/CJN.13391118. Epub 2019 Jun 3.

PMID:
31160317
4.

Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.

Selvin E, Wang D, McEvoy JW, Juraschek SP, Lazo M, Hamet P, Cooper ME, Marre M, Williams B, Harrap S, Chalmers J, Woodward M.

Diabetes Obes Metab. 2019 Aug;21(8):2017-2023. doi: 10.1111/dom.13755. Epub 2019 May 29.

PMID:
31050156
5.

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.

Rahman F, McEvoy JW, Ohkuma T, Marre M, Hamet P, Harrap S, Mancia G, Rodgers A, Selvin E, Williams B, Muntner P, Chalmers J, Woodward M.

Hypertension. 2019 Jun;73(6):1291-1299. doi: 10.1161/HYPERTENSIONAHA.118.12414.

PMID:
31030606
6.

New Blood Pressure Guidelines Pose Difficult Choices for Australian Physicians.

Harrap SB, Lung T, Chalmers J.

Circ Res. 2019 Mar 29;124(7):975-977. doi: 10.1161/CIRCRESAHA.118.314637. No abstract available.

PMID:
30920933
7.

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes.

Zhang Z, Tremblay J, Raelson J, Sofer T, Du L, Fang Q, Argos M, Marois-Blanchet FC, Wang Y, Yan L, Chalmers J, Woodward M, Harrap S, Hamet P, Luo H, Wu J.

J Hypertens. 2019 Apr;37(4):775-789. doi: 10.1097/HJH.0000000000001948.

PMID:
30817459
8.

Genetics of obesity in consanguineous populations - A road map to provide novel insights in the molecular basis and management of obesity.

Kapoor N, Chapla A, Furler J, Paul TV, Harrap S, Oldenburg B, Thomas N.

EBioMedicine. 2019 Feb;40:33-34. doi: 10.1016/j.ebiom.2019.01.004. Epub 2019 Jan 10. No abstract available.

9.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

10.

Cardiac function in pregnancy.

Zentner D, Harrap SB.

J Hypertens. 2018 Aug;36(8):1770. doi: 10.1097/HJH.0000000000001803. No abstract available.

PMID:
29952853
11.

Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.

Curl CL, Danes VR, Bell JR, Raaijmakers AJA, Ip WTK, Chandramouli C, Harding TW, Porrello ER, Erickson JR, Charchar FJ, Kompa AR, Edgley AJ, Crossman DJ, Soeller C, Mellor KM, Kalman JM, Harrap SB, Delbridge LMD.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e007451. doi: 10.1161/JAHA.117.007451.

12.

Involvement of human monogenic cardiomyopathy genes in experimental polygenic cardiac hypertrophy.

Prestes PR, Marques FZ, Lopez-Campos G, Lewandowski P, Delbridge LMD, Charchar FJ, Harrap SB.

Physiol Genomics. 2018 Sep 1;50(9):680-687. doi: 10.1152/physiolgenomics.00143.2017. Epub 2018 May 18.

PMID:
29775428
13.

Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.

Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, Harrap S, Woodward M.

Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311. Epub 2018 May 6.

PMID:
29603537
14.

Pericardial adipose and aromatase: A new translational target for aging, obesity and arrhythmogenesis?

Bernasochi GB, Boon WC, Curl CL, Varma U, Pepe S, Tare M, Parry LJ, Dimitriadis E, Harrap SB, Nalliah CJ, Kalman JM, Delbridge LMD, Bell JR.

J Mol Cell Cardiol. 2017 Oct;111:96-101. doi: 10.1016/j.yjmcc.2017.08.006. Epub 2017 Aug 16.

PMID:
28822806
15.

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.

Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, Chalmers J.

Cardiovasc Diabetol. 2017 Jul 27;16(1):95. doi: 10.1186/s12933-017-0574-y.

16.

Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.

Marques FZ, Prestes PR, Byars SG, Ritchie SC, Würtz P, Patel SK, Booth SA, Rana I, Minoda Y, Berzins SP, Curl CL, Bell JR, Wai B, Srivastava PM, Kangas AJ, Soininen P, Ruohonen S, Kähönen M, Lehtimäki T, Raitoharju E, Havulinna A, Perola M, Raitakari O, Salomaa V, Ala-Korpela M, Kettunen J, McGlynn M, Kelly J, Wlodek ME, Lewandowski PA, Delbridge LM, Burrell LM, Inouye M, Harrap SB, Charchar FJ.

J Am Heart Assoc. 2017 Jun 14;6(6). pii: e005971. doi: 10.1161/JAHA.117.005971.

17.

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.

Ohkuma T, Woodward M, Jun M, Muntner P, Hata J, Colagiuri S, Harrap S, Mancia G, Poulter N, Williams B, Rothwell P, Chalmers J; ADVANCE Collaborative Group.

Hypertension. 2017 Aug;70(2):461-468. doi: 10.1161/HYPERTENSIONAHA.117.09359. Epub 2017 Jun 5.

PMID:
28584014
18.

Familial Analysis of Epistatic and Sex-Dependent Association of Genes of the Renin-Angiotensin-Aldosterone System and Blood Pressure.

Scurrah KJ, Lamantia A, Ellis JA, Harrap SB.

Circ Cardiovasc Genet. 2017 Jun;10(3). pii: e001595. doi: 10.1161/CIRCGENETICS.116.001595.

PMID:
28506960
19.

Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts.

Patel SK, Wai B, Lang CC, Levin D, Palmer CNA, Parry HM, Velkoska E, Harrap SB, Srivastava PM, Burrell LM.

EBioMedicine. 2017 Apr;18:171-178. doi: 10.1016/j.ebiom.2017.03.036. Epub 2017 Mar 30.

20.

The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE study.

Blomster JI, Zoungas S, Woodward M, Neal B, Harrap S, Poulter N, Marre M, Williams B, Chalmers J, Hillis GS.

Diabetes Res Clin Pract. 2017 May;127:212-217. doi: 10.1016/j.diabres.2017.03.015. Epub 2017 Mar 21.

21.

Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene.

Tremblay J, Wang Y, Raelson J, Marois-Blanchet FC, Wu Z, Luo H, Bradley E, Chalmers J, Woodward M, Harrap S, Hamet P, Wu J.

Sci Rep. 2017 Mar 8;7:44114. doi: 10.1038/srep44114.

22.

Genetics of blood pressure: time to curate the collection.

Harrap SB, Charchar FJ.

J Hypertens. 2017 Jul;35(7):1360-1362. doi: 10.1097/HJH.0000000000001341. No abstract available.

PMID:
28244899
23.

Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.

Atkins ER, Hirakawa Y, Salam A, Woodward M, Cooper M, Hamet P, Harrap S, Lees K, Liu L, Mancia G, Marre M, Perkovic V, Poulter N, Williams B, Chalmers J, Rodgers A.

J Hypertens. 2017 Jun;35(6):1318-1325. doi: 10.1097/HJH.0000000000001287.

PMID:
28169881
24.

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.

Hamet P, Haloui M, Harvey F, Marois-Blanchet FC, Sylvestre MP, Tahir MR, Simon PH, Kanzki BS, Raelson J, Long C, Chalmers J, Woodward M, Marre M, Harrap S, Tremblay J.

J Hypertens. 2017 May;35 Suppl 1:S24-S32. doi: 10.1097/HJH.0000000000001241.

25.

Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.

Mohammedi K, Woodward M, Zoungas S, Li Q, Harrap S, Patel A, Marre M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Care. 2016 Dec;39(12):2270-2277. Epub 2016 Sep 27.

PMID:
27679583
26.

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.

Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P, Harrap S, Poulter N, Matthews DR, Marre M, Chalmers J; ADVANCE Collaborative Group.

Cardiovasc Diabetol. 2016 Sep 2;15(1):129. doi: 10.1186/s12933-016-0446-x.

27.

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.

van der Leeuw J, Visseren FL, Woodward M, van der Graaf Y, Grobbee DE, Harrap S, Heller S, Mancia G, Marre M, Poulter N, Zoungas S, Chalmers J.

Diabetologia. 2016 Dec;59(12):2603-2612. Epub 2016 Sep 1.

28.

Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk.

Wang Y, Hamet P, Thorin E, Tremblay J, Raelson J, Wu Z, Luo H, Jin W, Lavoie JL, Peng J, Marois-Blanchet FC, Tahir MR, Chalmers J, Woodward M, Harrap S, Qi S, Li CY, Wu J.

Eur J Hum Genet. 2016 Dec;24(12):1817-1825. doi: 10.1038/ejhg.2016.105. Epub 2016 Aug 17.

29.

Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.

Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Williams B, Lisheng L, Rodgers A, Mancia G, Neal B, Harrap S, Marre M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Care. 2016 Oct;39(10):1796-803. doi: 10.2337/dc16-0588. Epub 2016 Jul 25.

30.

Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and β-adrenergic challenge are different.

Bell JR, Curl CL, Harding TW, Vila Petroff M, Harrap SB, Delbridge LMD.

Biol Sex Differ. 2016 Jul 7;7:32. doi: 10.1186/s13293-016-0084-8. eCollection 2016.

31.

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.

Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, MacMahon S, Mancia G, Marre M, Matthews D, Neal B, Poulter N, Rodgers A, Williams B, Zoungas S; ADVANCE-ON Collaborative Group.

Diabetes Care. 2016 May;39(5):694-700. doi: 10.2337/dc15-2322. Epub 2016 Mar 22.

32.

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.

Hirakawa Y, Arima H, Webster R, Zoungas S, Li Q, Harrap S, Lisheng L, Hamet P, Mancia G, Poulter N, Neal B, Williams B, Rogers A, Woodward M, Chalmers J.

J Hypertens. 2016 Apr;34(4):781-7. doi: 10.1097/HJH.0000000000000841.

33.

Tripartite motif-containing 55 identified as functional candidate for spontaneous cardiac hypertrophy in the rat locus cardiac mass 22.

Prestes PR, Marques FZ, Lopez-Campos G, Booth SA, McGlynn M, Lewandowski P, Delbridge LM, Harrap SB, Charchar FJ.

J Hypertens. 2016 May;34(5):950-8. doi: 10.1097/HJH.0000000000000875.

PMID:
26886563
34.
35.

Telomere dynamics during aging in polygenic left ventricular hypertrophy.

Marques FZ, Booth SA, Prestes PR, Curl CL, Delbridge LM, Lewandowski P, Harrap SB, Charchar FJ.

Physiol Genomics. 2016 Jan;48(1):42-9. doi: 10.1152/physiolgenomics.00083.2015. Epub 2015 Oct 27.

36.

Socioeconomic position in young adulthood is associated with BMI in Australian families.

Scurrah KJ, Kavanagh AM, Bentley RJ, Thornton LE, Harrap SB.

J Public Health (Oxf). 2016 Jun;38(2):e39-46. doi: 10.1093/pubmed/fdv107. Epub 2015 Aug 19.

PMID:
26290476
37.

Blood Pressure Genetics Just Don't Add Up.

Harrap SB, Morris BJ.

Circ Cardiovasc Genet. 2015 Aug;8(4):541-3. doi: 10.1161/CIRCGENETICS.115.001188. No abstract available.

PMID:
26286727
38.

Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37:1353-1359.

Blomster JI, Zoungas S, Chalmers J, Li Q, Chow CK, Woodward M, Mancia G, Poulter N, Williams B, Harrap S, Neal B, Patel A, Hillis GS.

Diabetes Care. 2015 Jul;38(7):1393. doi: 10.2337/dc15-er07a. No abstract available.

PMID:
26106225
39.

Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure.

Tomaszewski M, Eales J, Denniff M, Myers S, Chew GS, Nelson CP, Christofidou P, Desai A, Büsst C, Wojnar L, Musialik K, Jozwiak J, Debiec R, Dominiczak AF, Navis G, van Gilst WH, van der Harst P, Samani NJ, Harrap S, Bogdanski P, Zukowska-Szczechowska E, Charchar FJ.

J Am Soc Nephrol. 2015 Dec;26(12):3151-60. doi: 10.1681/ASN.2014121211. Epub 2015 Apr 27.

40.

Characterizing the continuously acquired cardiovascular time series during hemodialysis, using median hybrid filter preprocessing noise reduction.

Wilson S, Bowyer A, Harrap SB.

Med Devices (Auckl). 2015 Jan 8;8:65-70. doi: 10.2147/MDER.S76409. eCollection 2015.

41.

Cardiac CaMKIIδ splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.

Bell JR, Raaijmakers AJ, Curl CL, Reichelt ME, Harding TW, Bei A, Ng DC, Erickson JR, Vila Petroff M, Harrap SB, Delbridge LM.

Int J Cardiol. 2015 Feb 15;181:288-96. doi: 10.1016/j.ijcard.2014.11.159. Epub 2014 Nov 26.

PMID:
25539453
42.

Non-proportional odds multivariate logistic regression of ordinal family data.

Zaloumis SG, Scurrah KJ, Harrap SB, Ellis JA, Gurrin LC.

Biom J. 2015 Mar;57(2):286-303. doi: 10.1002/bimj.201300137. Epub 2014 Oct 7.

PMID:
25287055
43.

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Arima H, Monaghan H, Joshi R, Colagiuri S, Cooper ME, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Lisheng L, Mancia G, Marre M, Matthews DR, Mogensen CE, Perkovic V, Poulter N, Rodgers A, Williams B, MacMahon S, Patel A, Woodward M; ADVANCE-ON Collaborative Group.

N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19.

44.

Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.

Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative group.

Diabetologia. 2014 Dec;57(12):2465-74. doi: 10.1007/s00125-014-3369-7. Epub 2014 Sep 17.

PMID:
25226881
45.

Measurement of absolute copy number variation reveals association with essential hypertension.

Marques FZ, Prestes PR, Pinheiro LB, Scurrah K, Emslie KR, Tomaszewski M, Harrap SB, Charchar FJ.

BMC Med Genomics. 2014 Jul 15;7:44. doi: 10.1186/1755-8794-7-44.

46.

Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.

Welsh P, Woodward M, Hillis GS, Li Q, Marre M, Williams B, Poulter N, Ryan L, Harrap S, Patel A, Chalmers J, Sattar N.

Diabetes Care. 2014 Aug;37(8):2202-10. doi: 10.2337/dc13-2625. Epub 2014 May 30.

PMID:
24879844
47.

[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome].

López-Jaramillo P, Sánchez RA, Diaz M, Cobos L, Bryce A, Parra-Carrillo JZ, Lizcano F, Lanas F, Sinay I, Sierra ID, Peñaherrera E, Bendersky M, Schmid H, Botero R, Urina M, Lara J, Foss MC, Márquez G, Harrap S, Ramírez AJ, Zanchetti A; Grupo de Especialistas da América Latina.

Arq Bras Endocrinol Metabol. 2014 Apr;58(3):205-25. Portuguese.

PMID:
24863082
48.

Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.

Arima H, Anderson C, Omae T, Woodward M, MacMahon S, Mancia G, Bousser MG, Tzourio C, Harrap S, Liu L, Neal B, Chalmers J; PROGRESS Collaborative Group.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1284-5. doi: 10.1136/jnnp-2014-307856. Epub 2014 May 14.

PMID:
24828894
49.

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.

Hirakawa Y, Arima H, Zoungas S, Ninomiya T, Cooper M, Hamet P, Mancia G, Poulter N, Harrap S, Woodward M, Chalmers J.

Diabetes Care. 2014 Aug;37(8):2359-65. doi: 10.2337/dc14-0199. Epub 2014 May 8.

PMID:
24812434
50.

The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.

Blomster JI, Zoungas S, Chalmers J, Li Q, Chow CK, Woodward M, Mancia G, Poulter N, Williams B, Harrap S, Neal B, Patel A, Hillis GS.

Diabetes Care. 2014;37(5):1353-9. doi: 10.2337/dc13-2727. Epub 2014 Feb 27. Erratum in: Diabetes Care. 2015 Jul;38(7):1393.

PMID:
24578358

Supplemental Content

Loading ...
Support Center